Diabetic nephropathy

Mark E. Molitch, Ralph A. DeFronzo, Marion J. Franz, William F. Keane, Carl Erik Mogensen, Hans Henrik Parving, Michael W. Steffes

Research output: Contribution to journalReview articlepeer-review

276 Scopus citations


Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

Original languageEnglish (US)
Pages (from-to)S94-S98
JournalDiabetes care
Issue numberSUPPL. 1
StatePublished - Jan 1 2003


Dive into the research topics of 'Diabetic nephropathy'. Together they form a unique fingerprint.

Cite this